Skip to main content
. Author manuscript; available in PMC: 2018 Apr 21.
Published in final edited form as: Cancer Invest. 2017 Mar 8;35(4):277–287. doi: 10.1080/07357907.2017.1289218

Table 2.

Mean post-intervention adjusted 8-iso-PGFα and 8oxodG by treatment groups.

Variable/treatment LS Mean LS Mean CI p value
8-iso-PGFα (pg/mL)a
 Intervention (n = 35) 696 524–923 .39
 Control (n = 34) 826 626–1091 Referent
8oxodG (ng/mL)a
 Intervention (n = 35) 2.0 1.4–2.8 .11
 Control (n = 34) 2.8 2.0–4.0 Referent
a

From analysis, using log values, mean values were back-transformed for presentation.

Adjustments: 8-iso-PGFα = baseline 8-iso-PGFα, age, and body mass index.

HHS Vulnerability Disclosure